<VariationArchive RecordType="classified" VariationID="496594" VariationName="NM_000799.4(EPO):c.20del (p.Pro7fs)" VariationType="Deletion" Accession="VCV000496594" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2018-03-20" MostRecentSubmission="2018-03-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="488086" VariationID="496594">
      <GeneList>
        <Gene Symbol="EPO" FullName="erythropoietin" GeneID="2056" HGNC_ID="HGNC:3415" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="100720468" stop="100723700" display_start="100720468" display_stop="100723700" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="100318422" stop="100321322" display_start="100318422" display_stop="100321322" Strand="+" />
          </Location>
          <OMIM>133170</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000799.4(EPO):c.20del (p.Pro7fs)</Name>
      <CanonicalSPDI>NC_000007.14:100721562:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="100721563" stop="100721563" display_start="100721563" display_stop="100721563" variantLength="1" positionVCF="100721562" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="100319186" stop="100319186" display_start="100319186" display_stop="100319186" variantLength="1" positionVCF="100319185" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>P7fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.100319187del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.100319187del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.100721564del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.100721564del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_021471.2" sequenceAccession="NG_021471" sequenceVersion="2" change="g.5765del">
            <Expression>NG_021471.2:g.5765del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000799.4" sequenceAccession="NM_000799" sequenceVersion="4" change="c.20del" MANESelect="true">
            <Expression>NM_000799.4:c.20del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000790.2" sequenceAccession="NP_000790" sequenceVersion="2" change="p.Pro7fs">
            <Expression>NP_000790.2:p.Pro7fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658683485" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="133170.0003" DB="OMIM" />
        <XRef Type="rs" ID="1554393458" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000799.4(EPO):c.20del (p.Pro7fs) AND Erythrocytosis, familial, 5" Accession="RCV000590862" Version="1">
        <ClassifiedConditionList TraitSetID="40715">
          <ClassifiedCondition DB="MedGen" ID="C4693552">Erythrocytosis, familial, 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-03-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-03-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-03-20" MostRecentSubmission="2018-03-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27651169</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29514032</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="40715" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38669" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Erythrocytosis, familial, 5</ElementValue>
                <XRef ID="MONDO:0033483" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ECYT5</ElementValue>
                <XRef Type="MIM" ID="617907" DB="OMIM" />
              </Symbol>
              <XRef ID="C4693552" DB="MedGen" />
              <XRef ID="MONDO:0033483" DB="MONDO" />
              <XRef Type="MIM" ID="617907" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1371469" SubmissionDate="2018-03-16" DateLastUpdated="2018-03-20" DateCreated="2018-03-20">
        <ClinVarSubmissionID localKey="133170.0003_ERYTHROCYTOSIS, FAMILIAL, 5" title="EPO, 1-BP DEL, 19C_ERYTHROCYTOSIS, FAMILIAL, 5" />
        <ClinVarAccession Accession="SCV000700069" DateUpdated="2018-03-20" DateCreated="2018-03-20" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-03-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 3-year-old girl with familial erythrocytosis-5 (ECYT5; 617907), Camps et al. (2016) identified a heterozygous 1-bp deletion, c.19delC (chr7.100,319,185TC-T, GRCh37) in the EPO gene. The mutation was predicted to result in a frameshift (P7fs). The mutation, which was found by targeted next-generation sequencing of 125 patients with erythrocytosis, was confirmed by Sanger sequencing. Her affected father also carried the mutation. Functional studies of the variant were not performed, but the variant was not found in the dbSNP (build 142) or ExAC databases.</Attribute>
              <Citation>
                <ID Source="PubMed">27651169</ID>
              </Citation>
              <XRef DB="OMIM" ID="617907" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Zmajkovic et al. (2018) demonstrated that the c.19delC mutation resulted in the use of an alternative promoter (P2) in intron 1, causing the production of functional transcripts and increased amounts of biologically active EPO compared to controls. The mechanism was similar to that observed with another mutation in the same region (c.32delG; 133170.0002).</Attribute>
              <Citation>
                <ID Source="PubMed">29514032</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPO" />
          </GeneList>
          <Name>EPO, 1-BP DEL, 19C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 19C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="133170.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ERYTHROCYTOSIS, FAMILIAL, 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1371469" TraitType="Disease" MappingType="Name" MappingValue="ERYTHROCYTOSIS, FAMILIAL, 5" MappingRef="Preferred">
        <MedGen CUI="C4693552" Name="Erythrocytosis, familial, 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

